Role and therapeutic potential of microRNAs in diabetes

Diabetes, Obesity and Metabolism

Volumn 11, Issue SUPPL. 4, 2009, Pages 118-129

  Kolfschoten, I G M ^a   Roggli, E ^a   Nesca, V ^a   Regazzi, R ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Diabetes; Gene expression; Insulin; Pancreatic islet; RNA

Indexed keywords

ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; LOCKED NUCLEIC ACID; MICRORNA; MORPHOLINO DERIVATIVE; NUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BIOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE MODEL; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; RNA BINDING; RNA STABILITY; RNA TRANSCRIPTION; RNA TRANSLATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN-SECRETING CELLS; MICE; MICRORNAS;

EID: 70350333116     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01118.x     Document Type: Article

References (79)

1. Donath MY, Storling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008, 29:334-350.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
3. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006, 116:1802-1812.
4. Parton LE, McMillen PJ, Shen Y. Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis. Am J Physiol Endocrinol Metab 2006, 291:E982-E994.
5. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL. Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 2001, 50:909-920.
6. D'Hertog W, Overbergh L, Lage K. Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol Cell Proteomics 2007, 6:2180-2199.
7. Lu H, Yang Y, Allister EM, Wijesekara N, Wheeler MB. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics 2008, 7:1434-1451.
8. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
9. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009, 11:228-234.
10. Yang Y, Wang YP, Li KB. MiRTif: a support vector machine-based microRNA target interaction filter. BMC Bioinformatics 2008, 9(Suppl. 12):S4.
11. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
12. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36:D149-D153.
13. Lall S, Grun D, Krek A. A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 2006, 16:460-471.
14. Vatolin S, Navaratne K, Weil RJ. A novel method to detect functional microRNA targets. J Mol Biol 2006, 358:983-996.
15. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
16. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
17. Orom UA, Lund AH. Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods 2007, 43:162-165.
18. Karginov FV, Conaco C, Xuan Z. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 2007, 104:19291-19296.
19. Hendrickson DG, Hogan DJ, Herschlag D, Ferrell JE, Brown PO. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS ONE 2008, 3:e2126.
20. Zhang L, Ding L, Cheung TH. Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. Mol Cell 2007, 28:598-613.
21. Hammell M, Long D, Zhang L. mirWIP: microRNA target prediction based on microRNA-containing ribonucleoprotein-enriched transcripts. Nat Methods 2008, 5:813-819.
22. Chang TC, Mendell JT. MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007, 8:215-239.
23. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 2006, 103:8721-8726.
24. Fiore R, Khudayberdiev S, Christensen M. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J 2009, 28:697-710.
25. He X, He L, Hannon GJ. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 2007, 67:11099-11101.
26. Chang TC, Yu D, Lee YS. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008, 40:43-50.
27. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
28. Guil S, Caceres JF. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 2007, 14:591-596.
29. Michlewski G, Guil S, Semple CA, Caceres JF. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Mol Cell 2008, 32:383-393.
30. Melo SA, Ropero S, Moutinho C. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009, 41:365-370.
31. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007, 16:1124-1131.
32. Wu M, Jolicoeur N, Li Z. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008, 29:1710-1716.
33. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008, 105:7269-7274.
34. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
35. Kedde M, Strasser MJ, Boldajipour B. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007, 131:1273-1286.
36. Shanmugam N, Reddy MA, Natarajan R. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J Biol Chem 2008, 283:36221-36233.
37. Suss C, Czupalla C, Winter C. Rapid changes of mRNA binding protein levels following glucose and IBMX stimulation of insulinoma INS-1 cells. Mol Cell Proteomics 2009, 8:393-408.
38. Abelson JF, Kwan KY, O'Roak BJ. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
39. Clop A, Marcq F, Takeda H. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006, 38:813-818.
40. Poy MN, Eliasson L, Krutzfeldt J. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
41. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 2008, 57:2708-2717.
42. Poy MN, Hausser J, Trajkovski M. miR-375 maintains normal pancreatic α- and β-cell mass. Proc Natl Acad Sci USA 2009, 106:5813-5818.
43. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006, 281:26932-26942.
44. Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the machinery of exocytosis of insulin-secreting cells by microRNAs. Biol Chem 2008, 389:305-312.
45. Baroukh N, Ravier MA, Loder MK. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cells lines. J Biol Chem 2007, 282:19575-19588.
46. Lovis P, Roggli E, Laybutt DR. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008, 57:2728-2736.
47. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription. RNA 2009, 15:287-293.
48. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 2007, 56:2938-2945.
49. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for mir-375 in pancreatic islet development. PLoS Biol 2007, 5:e203.
50. Bravo-Egana V, Rosero S, Molano RD, Pileggi A, Ricordi C, Dominguez-Bendala J. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun 2008, 366:922-926.
51. Correa-Medina M, Bravo-Egana V. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns 2009, 9:193-199.
52. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007, 21:2785-2794.
53. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 2009, 36:181-188.
54. Kajimoto K, Naraba H, Iwai N. MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA 2006, 12:1626-1632.
55. Esau C, Kang X, Peralta E. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004, 279:52361-52365.
56. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009, 58:1050-1057.
57. Chen JF, Mandel EM, Thomson JM. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233.
58. Xiao J, Luo X, Lin H. MicroRNA miR-133 represses HERG K + channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007, 282:12363-12367.
59. Paulussen A, Yang P, Pangalos M. Analysis of the human KCNH2 (HERG) gene: identification and characterization of a novel mutation Y667X associated with long QT syndrome and a non-pathological 9 bp insertion. Hum Mutat 2000, 15:483.
60. Carè A, Catalucci D, Felicetti F. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-608.
61. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
62. Kato M, Zhang J, Wang M. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 2007, 104:3432-3437.
63. Bradley SP, Rastellini C, da Costa MA, Kowalik TF, Bloomenthal AB, Brown M. Gene silencing in the endocrine pancreas mediated by short-interfering RNA. Pancreas 2005, 31:373-379.
64. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002, 2:243-247.
65. Snove O, Rossi JJ. Expressing short hairpin RNAs in vivo. Nat Methods 2006, 3:689-695.
66. Zeng Y, Cai X, Cullen BR. Use of RNA polymerase II to transcribe artificial microRNAs. Methods Enzymol 2005, 392:371-380.
67. Lodish HF, Zhou B, Liu G, Chen CZ. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008, 8:120-130.
68. Hutvagner G, Simard MJ, Mello CC, Zamore PD. Sequence-specific inhibition of small RNA function. PLoS Biol 2004, 2:E98.
69. Krutzfeldt J, Rajewsky N, Braich R. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
70. Esau CC. Inhibition of microRNA with antisense oligonucleotides. Methods 2008, 44:55-60.
71. Elmen J, Lindow M, Silahtaroglu A. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008, 36:1153-1162.
72. Elmen J, Lindow M, Schutz S. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452:896-899.
73. Wu B, Li Y, Morcos PA, Doran TJ, Lu P, Lu QL. Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol Ther 2009, 17:864-871.
74. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007, 4:721-726.
75. Lu J, Getz G, Miska EA. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
76. Volinia S, Calin GA, Liu CG. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
77. Chen X, Ba Y, Ma L. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
78. Chin LJ, Slack FJ. A truth serum for cancer-microRNAs have major potential as cancer biomarkers. Cell Res 2008, 18:983-984.
79. Stanczyk J, Pedrioli DM, Brentano F. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008, 58:1001-1009.